Summit Therapeutics
SMMT
SMMT
166 hedge funds and large institutions have $1.85B invested in Summit Therapeutics in 2024 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 52 increasing their positions, 34 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
35% more funds holding
Funds holding: 123 → 166 (+43)
1.38% more ownership
Funds ownership: 10.28% → 11.66% (+1.4%)
26% less call options, than puts
Call options by funds: $55.9M | Put options by funds: $75.5M
Holders
166
Holding in Top 10
2
Calls
$55.9M
Puts
$75.5M
Top Buyers
| 1 | +$74.4M | |
| 2 | +$46.6M | |
| 3 | +$26.3M | |
| 4 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$24.9M |
| 5 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
+$23.8M |
Top Sellers
| 1 | -$15.8M | |
| 2 | -$14.3M | |
| 3 | -$12.7M | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
-$8M |
| 5 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$7.35M |